{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:36:21Z","timestamp":1793756181168,"version":"4.6.1"},"reference-count":91,"publisher":"Informa UK Limited","issue":"16","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2021,11,2]]},"DOI":"10.1080\/14656566.2021.1959915","type":"journal-article","created":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T13:46:50Z","timestamp":1626961610000},"page":"2095-2103","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":24,"title":["Bexagliflozin for type 2 diabetes: an overview of the data"],"prefix":"10.1080","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1790-2062","authenticated-orcid":false,"given":"Omar","family":"Azzam","sequence":"first","affiliation":[{"name":"Dobney Hypertension Centre, School of Medicine - Royal Perth Hospital Unit, Royal Perth Hospital Research Foundation, Faculty of Medicine, Dentistry & Health Sciences, The University of Western Australia, Perth, Australia"},{"name":"Department of Medicine, Royal Perth Hospital, Perth, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Revathy","family":"Carnagarin","sequence":"additional","affiliation":[{"name":"Dobney Hypertension Centre, School of Medicine - Royal Perth Hospital Unit, Royal Perth Hospital Research Foundation, Faculty of Medicine, Dentistry & Health Sciences, The University of Western Australia, Perth, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie Marisol","family":"Lugo-Gavidia","sequence":"additional","affiliation":[{"name":"Dobney Hypertension Centre, School of Medicine - Royal Perth Hospital Unit, Royal Perth Hospital Research Foundation, Faculty of Medicine, Dentistry & Health Sciences, The University of Western Australia, Perth, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janis","family":"Nolde","sequence":"additional","affiliation":[{"name":"Dobney Hypertension Centre, School of Medicine - Royal Perth Hospital Unit, Royal Perth Hospital Research Foundation, Faculty of Medicine, Dentistry & Health Sciences, The University of Western Australia, Perth, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vance B.","family":"Matthews","sequence":"additional","affiliation":[{"name":"Dobney Hypertension Centre, School of Medicine - Royal Perth Hospital Unit, Royal Perth Hospital Research Foundation, Faculty of Medicine, Dentistry & Health Sciences, The University of Western Australia, Perth, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1765-0195","authenticated-orcid":false,"given":"Markus P.","family":"Schlaich","sequence":"additional","affiliation":[{"name":"Dobney Hypertension Centre, School of Medicine - Royal Perth Hospital Unit, Royal Perth Hospital Research Foundation, Faculty of Medicine, Dentistry & Health Sciences, The University of Western Australia, Perth, Australia"},{"name":"Departments of Cardiology and Nephrology, Royal Perth Hospital, Perth, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,7,29]]},"reference":[{"key":"cit0001","unstructured":"IDF. IDF diabetes atlas 9th edition. 2019 [cited 2021 Apr 2nd]. https:\/\/diabetesatlas.org\/en."},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k1497"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2017-3459"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)07019-6"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0806470"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60576-4"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0802987"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2011.537"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61969-3"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-S006"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.7326\/M17-0939"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.9400"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra041001"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2011.01511.x"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2016.170"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-051013-110046"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.2337\/db13-0604"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2011.243"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-156-6-201203200-00003"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-3055"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-159-4-201308200-00007"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2015.07.011"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2012-001007"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-0606"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-2491"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(15)00417-9"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-1096"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1111\/jch.12747"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.3109\/08037051.2015.1116258"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.005686"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.004007"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2013.356"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1186\/s40360-017-0125-x"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2020.1751815"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-017-0511-0"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1177\/1753944720939383"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000001434"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacbts.2019.11.007"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2016.11.004"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1991.03470210076036"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0800885"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1002\/bdd.1909"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13101"},{"key":"cit0044","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.116.309326"},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.110.223545"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-016-0473-7"},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-014-0148-1"},{"key":"cit0048","unstructured":"FDA. Guidance for industry in diabetes mellitus - evaluating cardiovascular risk in new antidiabetic therapires to treat type 2 diabetes. 2008 [cited 2021 Apr 24th]; Available from: https:\/\/www.federalregister.gov\/documents\/2008\/12\/19\/E8-30086\/guidance-for-industry-on-diabetes-mellitus-evaluating-cardiovascular-risk-in-new-antidiabetic."},{"key":"cit0049","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa072761"},{"key":"cit0050","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60953-3"},{"key":"cit0051","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504720"},{"key":"cit0052","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1611925"},{"key":"cit0053","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1812389"},{"key":"cit0054","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2013.05.007"},{"key":"cit0055","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12829"},{"key":"cit0056","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2004967"},{"key":"cit0057","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1911303"},{"key":"cit0058","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2022190"},{"key":"cit0059","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31824-9"},{"key":"cit0060","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1811744"},{"key":"cit0061","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfz290"},{"key":"cit0062","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfaa234"},{"key":"cit0063","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2024816"},{"key":"cit0064","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.051675"},{"key":"cit0065","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(20)30162-5"},{"key":"cit0066","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2017.12.027"},{"key":"cit0067","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.20211220"},{"key":"cit0068","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112523"},{"key":"cit0069","unstructured":"PubChem PD Bexagliflozin. 2021. [cited 2021 May 3rd]; Available from: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Bexagliflozin."},{"key":"cit0070","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2011.01.001"},{"key":"cit0071","doi-asserted-by":"publisher","DOI":"10.1080\/00498254.2019.1654634"},{"key":"cit0072","doi-asserted-by":"crossref","unstructured":"Kuchay MS, Farooqui KJ, Mishra SK, et al. In: Islam MS, editors. Glucose lowering efficacy and pleiotropic effects of sodium-glucose cotransporter 2 inhibitors, in Diabetes: from Research to Clinical Practice: Volume 4. Springer International Publishing; 2021. p. 213\u2013230.","DOI":"10.1007\/5584_2020_479"},{"key":"cit0073","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13928"},{"key":"cit0074","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13833"},{"key":"cit0075","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13801"},{"key":"cit0076","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2019.03.417"},{"issue":"1","key":"cit0077","first-page":"32","volume":"69","author":"McMurray JJV","year":"2020","journal-title":"Clinical Trial. Diabetes"},{"key":"cit0078","unstructured":"FDA. FDA approves new treatment for a type of heart failure. 2020 [cited 2021 May 9th]. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-new-treatment-type-heart-failure"},{"key":"cit0079","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30748-0"},{"key":"cit0080","unstructured":"AJMC. FDA approves canagliflozin to prevent kidney failure, hospitalization for heart failure. 2019 [cited 2021 May 9th]. https:\/\/www.ajmc.com\/view\/fda-approves-canagliflozin-to-prevent-kidney-failure-hospitalization-for-heart-failure"},{"key":"cit0081","unstructured":"ACC. FDA approves dapagliflozin to treat CKD. 2021 [cited 2021 May 9th]. https:\/\/www.acc.org\/latest-in-cardiology\/articles\/2021\/05\/03\/19\/11\/fda-approves-dapagliflozin-to-treat-ckd."},{"key":"cit0082","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-018-4729-5"},{"key":"cit0083","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-019-05039-w"},{"key":"cit0084","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-S009"},{"key":"cit0085","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12825"},{"key":"cit0086","doi-asserted-by":"publisher","DOI":"10.1111\/jch.12425"},{"key":"cit0087","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2014.919907"},{"key":"cit0088","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.2886"},{"key":"cit0089","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-3167"},{"key":"cit0090","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12742"},{"key":"cit0091","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13255"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14656566.2021.1959915","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T08:57:22Z","timestamp":1635757042000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14656566.2021.1959915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,29]]},"references-count":91,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2021,11,2]]}},"alternative-id":["10.1080\/14656566.2021.1959915"],"URL":"https:\/\/doi.org\/10.1080\/14656566.2021.1959915","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,29]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-05-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}